The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Thursday, September 21, 2017
In a recent study, researchers produced genetically engineered antibodies with the highest activity and breadth of coverage yet seen against HIV-1.
read more
Thursday, September 21, 2017
Audentes Therapeutics has commenced dosing of patients in ASPIRO, a Phase 1/2 clinical trial of AT132 for the treatment of X-Linked Myotubular ...
read more
Friday, September 22, 2017
Natera has entered into a research collaboration with Aarhus University to leverage the company's Signatera personalized liquid biopsy technology to ...
read more
Friday, September 22, 2017
Allergan announced top-line results from new data for the CENTAUR Phase 2b study which supports the anti-fibrotic efficacy and safety of Cenicriviroc ...
read more
Monday, September 25, 2017
Aegerion has agreed to plead guilty to two misdemeanor counts of violating the FD&C Act involving the introduction of misbranded Juxtapid into ...
read more
Monday, September 25, 2017
Geisinger and Boehringer Ingelheim announced a collaboration to develop a risk-prediction model for three critical health outcomes commonly associated...
read more
Monday, September 25, 2017
Infinity has expanded its existing clinical collaboration with Bristol-Myers Squibb evaluating IPI-549 in combination with Opdivo.
read more
Monday, September 25, 2017
AbbVie Inc., Bristol-Myers Squibb
AbbVie Bristol-Myers Squibb announced a collaboration to evaluate the combination of ABBV-399 and Opdivo in c-Met overexpressing NSCLC.
read more
Tuesday, September 26, 2017
Medicago announced the start of a Phase 3 efficacy study for its seasonal quadrivalent influenza vaccine candidate.
read more
Tuesday, September 26, 2017
Lannett has received approval from the FDA of its ANDA for Dexmethylphenidate Hydrochloride Tablets, 2.5 mg, 5 mg, and 10 mg, the therapeutic ...
read more
Wednesday, September 27, 2017
Lannett has received approval from the FDA of its ANDA for Oxycodone and Acetaminophen Tablets, USP, 5 mg/325 mg and 10 mg/325 mg, the therapeutic ...
read more
Wednesday, September 27, 2017
The FDA announced the names of the companies selected to participate in a first-of-its kind pilot program that will help revolutionize digital health ...
read more
Wednesday, September 27, 2017
Audentes Therapeutics announced that the FDA has granted Rare Pediatric Disease and Fast Track designations for AT132.
read more
Tuesday, October 03, 2017
AOBiome announced the initiation of patient enrollment in AOBiome's Phase 1b/2a clinical trial of the company's AOB product candidate, for the ...
read more
Tuesday, October 03, 2017
Regen BioPharma scientists have used a standard biochemical assay to determine if some of its small molecules that have been shown to activate NR2F6 ...
read more